← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2009First marketed drug
Jun 25, 2018First NDA
Jul 27, 2018Last known activity
Aug 31, 2017
Defunct as of Jun 6, 2019
Timeline
2000s
- Jul 1, 2002
Achaogen, Inc.— Founded
2010s
- Jun 25, 2018
plazomicin— NDA Secondary Org
- Jul 27, 2018
plazomicin— NDA Organization
- Jun 6, 2019
Achaogen, Inc.— Defunct
Drugs by trial phase (10 distinct, 12 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (23)
- NCT03270553Study directorPhase 1Aug 31, 2017
- NCT03270553Lead sponsorPhase 1Aug 31, 2017
- NCT03177278Study directorPhase 1Jun 6, 2017
- NCT03177278Lead sponsorPhase 1Jun 6, 2017
- NCT03163550Study directorPhase 1May 17, 2017
- NCT03163550Lead sponsorPhase 1May 17, 2017
- NCT02486627Lead sponsorPhase 3Jan 1, 2016
- NCT02486627Study directorPhase 3Jan 1, 2016
- NCT01970371Study directorPhase 3Sep 1, 2014
- NCT01970371Lead sponsorPhase 3Sep 1, 2014
- NCT01870245Study directorPhase 1May 1, 2013
- NCT01870245Lead sponsorPhase 1May 1, 2013
- NCT01597947Study directorPhase 1May 1, 2012
- NCT01597947Lead sponsorPhase 1May 1, 2012
- NCT01514929Lead sponsorPhase 1Oct 1, 2011
Details
- Founded
- South San Francisco, CA, US Jul 1, 2002
- First NDA
- Jul 27, 2018
- Last known activity
- Aug 31, 2017
Designations held
- Priority review